Clinical Trials in Los Angeles

Showing 3661-3680 of 16,901 trials

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

NCT06107881

One goal of this research is to conduct a non-inferiority trial of telerehabilitation versus in-office care to provide follow-up training to individuals with low vision to enhance their quality of life by using magnification devices and/or visual assistive mobile apps for important daily activities, such as reading and/or other valued tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, which can be essentially eliminated with telerehabilitation. Another goal of this project is to determine whether significant changes in environmental data collected by Bluetooth low energy beacon sensors can be used as a solution to monitor and indicate when low vision patients' have abandoned the use of their magnification devices, which has the potential to substantially enhance patient management by providing timely low vision rehabilitation services.

Low VisionLow Vision Aids

University of California, Los Angeles350 participantsStarted Dec 2023

Fullerton, California, United States • Grass Valley, California, United States • Los Angeles, California, United States +6 more locations

RECRUITINGNA< 1 mile

In-patient SCC TMS

NCT05645575

The investigators are studying the feasibility, safety, and tolerability of administering accelerated repetitive Transcranial magnetic stimulation(a-rTMS) at frequencies other than standard 10 Hz for in-patient Subjects diagnosed with Major Depressive Disorder. Participants will be recruited from the Resnick Neuropsychiatric Hospital. This study will enroll 30 participants who will undergo up to three brain activity recordings, one MRI scan, one TMS procedure to determine the appropriate frequency and intensity for treatment, daily symptom assessments, and 25 TMS treatments. Participants will be asked to participate for up to 2 weeks.

Major Depressive Disorder

University of California, Los Angeles30 participantsStarted Apr 2025

Los Angeles, California, United States

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

In-patient SCC TMS

Find Trials by Condition in Los Angeles

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids

Model-based Electrical Brain Stimulation

Intermittent Theta Burst Stimulation for MDD

Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects

EchoTip AcuCore Post-Market Clinical Study

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

Weight Bearing After Pelvis and Acetabulum Fracture Fixation

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial